Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis.
Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis.
复制标题
DOI:
10.1016/j.redox.2023.102771
复制
发表时间:
2023-08
期刊:
影响因子:
11.4
通讯作者:
Yang, Xiaofeng
中科院分区:
文献类型:
--
作者:
Xu, Keman;Saaoud, Fatma;Shao, Ying;Lu, Yifan;Wu, Sheng;Zhao, Huaqing;Chen, Kaifu;Vazquez-Padron, Roberto;Jiang, Xiaohua;Wang, Hong;Yang, Xiaofeng
关键词:
To identify metabolomic reprogramming in early hyperlipidemia, unbiased metabolome was screened in four tissues from ApoE−/− mice fed with high fat diet (HFD) for 3 weeks. 30, 122, 67, and 97 metabolites in the aorta, heart, liver, and plasma, respectively, were upregulated. 9 upregulated metabolites were uremic toxins, and 13 metabolites, including palmitate, promoted a trained immunity with increased syntheses of acetyl-CoA and cholesterol, increased S-adenosylhomocysteine (SAH) and hypomethylation and decreased glycolysis. The cross-omics analysis found upregulation of 11 metabolite synthetases in ApoE‾/‾ aorta, which promote ROS, cholesterol biosynthesis, and inflammation. Statistical correlation of 12 upregulated metabolites with 37 gene upregulations in ApoE‾/‾ aorta indicated 9 upregulated new metabolites to be proatherogenic. Antioxidant transcription factor NRF2−/− transcriptome analysis indicated that NRF2 suppresses trained immunity-metabolomic reprogramming. Our results have provided novel insights on metabolomic reprogramming in multiple tissues in early hyperlipidemia oriented toward three co-existed new types of trained immunity. Differential metabolic reprogramming promoted atherogenesis, mainly in the aorta but not in the heart, liver, or plasma. The first metabolomic data identified that early hyperlipidemia-induced trained immunity for inflammatory enhancement. Our findings highlighted for the first time that atherogenic metabolites facilitate metabolite-sensor partner signaling. Cross-omic analysis identified that metabolic reprogramming is not only enzymatic reactions but also transcriptomic regulation. Antioxidant transcription factor NRF2 acts as a new inhibitor for trained immunity-metabolic reprogramming.
登录
查看更多内容
DOI:
10.1016/j.bbadis.2015.10.019
发表时间:
2016-01
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
Barroso M;Kao D;Blom HJ;Tavares de Almeida I;Castro R;Loscalzo J;Handy DE
通讯作者:
Handy DE
影响因子:
3.7
作者:
Kuang CY;Yang TH;Zhang Y;Zhang L;Wu Q
通讯作者:
Wu Q
影响因子:
20.3
作者:
Cheng, Zhongjian;Jiang, Xiaohua;Wang, Hong
通讯作者:
Wang, Hong
DOI:
10.1016/j.jacbts.2021.09.011
发表时间:
2022-03
期刊:
JACC. Basic to translational science
影响因子:
--
作者:
Calvier L;Herz J;Hansmann G
通讯作者:
Hansmann G
影响因子:
64.5
作者:
Bekkering, Siroon;Arts, Rob J. W.;Netea, Mihai G.
通讯作者:
Netea, Mihai G.